Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TherOx gets $30mm through its Series J round

Executive Summary

TherOx, which makes a cardiovascular device that dissolves oxygen in the bloodstream post-heart attack to prevent tissue necrosis, has raised $30mm through the closing of its Series J venture round. New and lead investor DAG Ventures was joined by current backers, including Kleiner, Perkins, Caufield & Byers, Integral Capital Partners, Aperture Venture Partners, Cross Creek Capital, and New Science Ventures.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies